Toubi E - Search Results

1

Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus.

Toubi E, Khamashta MA, Panarra A, Hughes GR. Toubi E, et al. Am J Med. 1995 Oct;99(4):397-401. doi: 10.1016/s0002-9343(99)80188-0. Am J Med. 1995. PMID: 7573096

2

Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?

Shoenfeld Y, Meroni PL, Toubi E. Shoenfeld Y, et al. Among authors: toubi e. Curr Opin Rheumatol. 2009 Sep;21(5):495-500. doi: 10.1097/BOR.0b013e32832effdd. Curr Opin Rheumatol. 2009. PMID: 19593144 Review.

3

Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus Patients.

Sthoeger Z, Lorber M, Tal Y, Toubi E, Amital H, Kivity S, Langevitz P, Asher I, Elbirt D, Agmon Levin N. Sthoeger Z, et al. Among authors: toubi e. Isr Med Assoc J. 2017 Jan;19(1):44-48. Isr Med Assoc J. 2017. PMID: 28457114

4

Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis.

Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin NA, Shoenfeld Y, Toubi E. Vadasz Z, et al. Among authors: toubi e. Clin Immunol. 2016 Mar;164:114-8. doi: 10.1016/j.clim.2016.02.004. Epub 2016 Feb 13. Clin Immunol. 2016. PMID: 26883681

5

A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.

Vadasz Z, Haj T, Balbir A, Peri R, Rosner I, Slobodin G, Kessel A, Toubi E. Vadasz Z, et al. Among authors: toubi e. Semin Arthritis Rheum. 2014 Jun;43(6):767-71. doi: 10.1016/j.semarthrit.2013.11.010. Epub 2013 Dec 4. Semin Arthritis Rheum. 2014. PMID: 24461079

6

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.

Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D, Kessel A, Kessler O, Neufeld G, Toubi E. Vadasz Z, et al. Among authors: toubi e. Arthritis Res Ther. 2012 Jun 14;14(3):R146. doi: 10.1186/ar3881. Arthritis Res Ther. 2012. PMID: 22697500 Free PMC article.

7

[Leflunomide in systemic lupus erythematosus].

Kessel A, Toubi E. Kessel A, et al. Among authors: toubi e. Harefuah. 2002 Apr;141(4):355-7, 409. Harefuah. 2002. PMID: 12017890 Hebrew.

8

Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death.

Gonen R, Lavi N, Attias D, Schliamser L, Borochowitz Z, Toubi E, Ohel G. Gonen R, et al. Among authors: toubi e. Am J Obstet Gynecol. 2005 Mar;192(3):742-6. doi: 10.1016/j.ajog.2004.12.050. Am J Obstet Gynecol. 2005. PMID: 15746666

9

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.

Buchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GR. Buchanan NM, et al. Among authors: toubi e. Ann Rheum Dis. 1996 Jul;55(7):486-8. doi: 10.1136/ard.55.7.486. Ann Rheum Dis. 1996. PMID: 8774170 Free PMC article.

10

High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.

Toubi E, Kessel A, Shoenfeld Y. Toubi E, et al. Hum Immunol. 2005 Apr;66(4):395-402. doi: 10.1016/j.humimm.2005.01.022. Hum Immunol. 2005. PMID: 15866703 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results